首页 / 专利分类库 / 有机化学 / 杂环化合物 / 杂环化合物,含五元环,有两个氮原子和1个氧原子作为仅有的杂环原子
序号 专利名 申请号 申请日 公开(公告)号 公开(公告)日 发明人
21 CNS 흥분제 KR1019810003719 1981-10-02 KR1019830007594A 1983-11-04 라인하르트피터스타인
내용없음
22 CNS 흥분제 및 항 고혈압제 KR1019810003720 1981-10-02 KR1019830007595A 1983-11-04 레인하르드트페터스타인
내용없음
23 Emitting device and device used therein JP2003546416 2002-11-15 JP2005510036A 2005-04-14 ピロウ,ジョナサン,ニジェール,ジェラルド; フランプトン,マイケル,ジョン
下記の化合物(I)、(II)又は(III)の少なくとも1つを含有する発光装置。
【化1】

【化2】

【化3】

ここで、R 1及びR 2は、同じか異なり、Hを含まない有機置換基である。
ここで、R 3及びR 5は、ハロゲン及びHを含まない有機置換基から選択される。
ここで、R 4 、R 6 、R 7 、R 8 、R 9及びR 10は、H、ハロゲン及び有機置換基からそれぞれ独立して選択される。
ここで、R 1 、R 2 、R 3 、R 4 、R 5 ,R 6 、R 7 、R 8 、R 9 、及びR 10が還系を形成するために選択的に縮合される。 ただし、R 3及びR 5の1つが縮合環の一部ではなく、また、R 1及びR 2が環を形成するために縮合しない。
ここで、R 3及びR 4の、又はR 5及びR 6両方ではなくどちらかは、環を形成するために互いに縮合される。
24 Di - or triaza - spiro [4,5] decane derivative JP16194399 1999-06-09 JP3369123B2 2003-01-20 アンドレア・セスラ; ゲオ・アダム; ザビーネ・コルツェヴスキ; シュテファン・レーヴァー; フランソワ・ジェンク; ユルゲン・ヴィッヒマン
25 The novel heterocyclic compounds, their use in the treatment of these manufacturing methods and pharmaceutical compositions containing them, as well as diabetes and related diseases JP53930797 1997-06-30 JP2002515874A 2002-05-28 ガーラム、ランガ・マッドハバン; チャクラバルティ、ラニャン; パカラ、サルマ・ケー・エス; パラセリ、ラオ・ベーマ; ラマニャム、ラジャゴパラン; ローライ、ビッダヤ・ブースハン; ローライ、ブライ・ブースハン
(57)【要約】
26 Di- or triaza-spiro[4,5]decane derivative JP16194399 1999-06-09 JP2000026466A 2000-01-25 ADAM GEO; CESURA ANDREA; JENCK FRANCOIS; KOLCZEWSKI SABINE; ROEVER STEPHAN; WICHMANN JUERGEN
PROBLEM TO BE SOLVED: To obtain a novel compound that is an agonist and antagonist of Orphanin FQ(OFQ) receptor and is useful for treatment of psychological disorder, neurological disorder and physiological disorder. SOLUTION: This is a new compound represented by formula I [R1 is a (substituted) 6-10C cycloalkyl, decahydro-naphthalen-1-yl, indan-1-yl, or the like; R2 is H, a lower alkyl, =O, or a (substituted) phenyl; group A is a (substituted) cyclohexyl or phenyl; X is -CH(OH)-, -C(O)- or the like; Y is -CH2-, -CH=, -N= or the like; a and b mean actual additive bonds], typically (RS)-8-(cis-4- isopropyl-cyclohexyl)-1-phenyl-1,8-diaza-spiro[4.5]decan-4-ol. The compound of formula I is prepared by reductive amination of a compound of formula II with a compound of formula II.
27 Chloroacetamide derivatives JP1953583 1983-02-08 JPH0645617B2 1994-06-15 カ−ル・ゼツキンガ−; カ−ルハインツ・ミルツナ−; フレツド・ク−ネン
28 JPH0564634B2 - JP5361485 1985-03-18 JPH0564634B2 1993-09-16 SHIMIZU NOBORU; ISHIWATARI HIROYUKI; KUNIEDA HISASHI; OOTA TOMIO; ISHIHAMA HIROSHI; UCHIDA YASUYOSHI
29 JPH0149353B2 - JP18640985 1985-08-23 JPH0149353B2 1989-10-24 OKAZAKI MITSUO; YAMAGUCHI TERUHIRO; SASAKI MASAOMI
30 Heterocyclic thioalanine derivative JP8387786 1986-04-11 JPS62240663A 1987-10-21 MORITA YOSHIMI; HOSHIIDE YASUO; TANIGUCHI SEIRO; OKADA KAZUO; ANDO RYOICHI; TAKASHIMA JUNKO
NEW MATERIAL:A compound of formula I (P is formula VI-VIII; Q is O, S, NR<2>; Z is N, CR<8>; R<1>-R<8> are H, alkyl, further R<1> is H, alkyl; R<3> and R<4> incorporate to form alicyclic or aromatic ring; dotted line represents a bond existing in some cases; A is H, amino acid or oligopeptide which may have protecting group of the residue after removing OH from terminal CO2H or protecting group, B is OH, amino acid or oligopeptide residue which may have protecting groups after removing H from terminal NH2, protecting group). EXAMPLE:S-(2-Methyl-1,3,4-thiadiazol-5-yl)-D-cysteine. USE:A synthetic intermediate of inhibitor of cell wall biosynthesis and antibacterial agent. PREPARATION:The reaction of a compound of formula II (it is protected, when P contains functional groups active in the substitution reaction) with another compound of formula III (R<9> is OH, protecting group) in the presence of a base is followed by deprotection, when necessary, to give a compound of formula V.
31 Pyrazolesulfonamide derivative, production thereof and herbicide JP29547685 1985-12-27 JPS62155273A 1987-07-10 YAMAMOTO SUSUMU; TSUNODA TAKUYA; SATO TOSHIAKI; MORIMOTO KATSUYUKI; OYA EIICHI; IGAI TAKASHI; NAWAMAKI TSUTOMU; HATTORI KENJI
NEW MATERIAL:A compound expressed by formulas I {Q is formula IIWV (R 1 and R 2 are H, halogen, NO 2, alkyl, etc.; R 4 and R 7 are H, halogen or alkyl; R 6 and R 8WR 10 are H or alkyl; W 1 is O, S, etc.), etc.; m is 0W2; R is H or alkyl; B and D are R, halogen, phenyl, etc.; E is H, alkyl, etc.; W is O, S, etc.; G is formula VI [X and Y are H, alkyl, alkoxy, etc.; Z is N or CR 25 (R 25 is H, alkyl, etc.), etc.]}. EXAMPLE: N-[(4,6-Dimethoxypyrimidin-2-yl)aminocarbonyl]-1-methyl-4-(5-methyl- 1,3,4-oxadiazo-2-yl)pyrazole-5-sulfonamide. USE: A herbicide. PREPARATION: A pyrazolesulfonyl (thio)isocyanate derivative expressed by formula VII (W' is O or S) is reacted with an aminopyridine derivative expressed by formula VIII, etc., to afford the aimed compound expressed by formula I (W is W'). COPYRIGHT: (C)1987,JPO&Japio
32 5-(3-(9-ethyl)carbazolyl)tetrazole and its production JP18640985 1985-08-23 JPS61218587A 1986-09-29 OKAZAKI MITSUO; YAMAGUCHI TERUHIRO; SASAKI MASAOMI
NEW MATERIAL:The compound of the formula. USE: A synthetic intermediate of 5-[3-(9-ethyl)carbazolyl]-1,3,4-oxadiazole derivative which is an organic photoelectric conductor. PREPARATION: The reaction of 3-cyano-9-ethylcarbazole with sodium azide is effected in an organic solvent such as methyl cellosolve to give the objective compound. COPYRIGHT: (C)1986,JPO&Japio
33 Novel 1,4-dihydropyridine derivative JP5361485 1985-03-18 JPS61212581A 1986-09-20 SHIMIZU NOBORU; ISHIWATARI HIROYUKI; KUNIEDA HISASHI; OTA TOMIO; ISHIHAMA HIROSHI; UCHIDA YASUYOSHI
NEW MATERIAL:The compound of formula I (R1 is phenyl or pyridyl which may be substituted with 1-2 halogen, nitro or CF3, or benzoxadiazolyl; R2 is lower alkyl; R3 is H, formyl, carboxyl, etc.; A is straight-chain or branched- chain lower alkylene; B is 1-6C straight-chain alkylene; X is direct bond or O). EXAMPLE:2, 6-Dimethyl-4-(3-nitrophenyl)-1, 4-dihydropyridine-3, 5-dicarboxylic acid 3-methyl ester 5-[4-(1-imidazolylmethyl)phenylmethyl] ester. USE:Vasodilator, hypotensor, antithrombotic agent and antiarteriosclerotic agent. PREPARATION:The compound of formula I can be produced by reacting the compound of formula II with N,N'-carbonyldiimidazole in an inert solvent and reacting the reaction product with the compound of formula III.
34 Acetoacetic acid ester derivative JP2498685 1985-02-12 JPS61186371A 1986-08-20 ONO SACHIO; MIZUKOSHI SEISHI; KOMATSU OSAMU
NEW MATERIAL:The acetoacetic acid ester derivative of formula I (R 1 is lower alkyl such as methyl, ethyl, propyl, isopropyl, etc., or cyclopropylmethyl). EXAMPLE: Ethyl 2-acetyl-3-(2,1,3-benzoxadiazol-4-yl)-3-bromopropionate. USE: Useful as an intermediate raw material for 1,4-dihydropyridine derivative useful pharmacologically as a vasodilator and remedy for hypertension. PREPARATION: The compound of formula I can be produced by reacting the 4-bromomethyl-benz-2,1,3-oxadiazole of formula II with the acetoacetic acid ester of formula III in the presence of a base. COPYRIGHT: (C)1986,JPO&Japio
35 JPS60501813A - JP50287184 1984-07-05 JPS60501813A 1985-10-24
36 Tetrahydrobenzothiazole derivative and herbicide containing said derivative JP6192483 1983-04-08 JPS59186979A 1984-10-23 AOKI KATSUMICHI; SHIDA TAKAFUMI; ARAHORI HIDEO; KUMAZAWA SATOSHI; SHIMIZU SUSUMU; WATANABE TAKEO; KANDA YOUICHI; SATAKE KEIGO; YAMAZAKI SHIROU; SHINKAWA HIROE; SENDA TSUNEAKI
NEW MATERIAL:A tetrahydrobenzothiazole derivative of formula I (R is methyl, ethyl or propyl; R 1 is H, hydroxyl group, methoxyl group, acetoxy, propionyloxy, butyryloxy, chloroacetoxy, methoxyacetoxy, alkylamino substituted by 1W 4C alkyl group or dialkylamino; R 2 is H or together with R 1 form oxygen atoms of double bond; X is methylene, hydroxymethylene or carbonyl, etc.). EXAMPLE: 1-(5, 5-Dimethyl-4, 5, 6,7-tetrahydro-7-oxo-2-benzothiazolyl)-3-ethylimidazolidinetrione. USE: A herbicide exhibiting improved activity against gamineous and broad-leaved weeds, etc. PREPARATION: For example, a compound of formula II is reacted with glyoxal or base oxalyl, etc. to give the aimed compound of formula I . COPYRIGHT: (C)1984,JPO&Japio
37 JPS57502057A - JP50047382 1981-12-14 JPS57502057A 1982-11-18
38 JPS57501480A - JP50316181 1981-09-14 JPS57501480A 1982-08-19
39 1*2*44oxadiazolinee55one derivative* its manufacture and drug composition containing same JP14066880 1980-10-09 JPS5661375A 1981-05-26 KAARUMAAN TAKAACHIYU; KISU AIZERUTO; ANTARU SHIMAI; PEETERU RITERAATEI NAJI; HETEIEI PATSUPU; ECHIERII PUSHIYUKAASHIYU; RAASURO SEKERESHIYU; JIYURA PATSUPU; SHIAANDORU BIRAAGU; EBUA UDOUBUARUDEI
40 JPS4985063A - JP119873 1972-12-23 JPS4985063A 1974-08-15
QQ群二维码
意见反馈